![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/113 | |
A61K 31/711 | |||
C07H 21/00 | |||
A61P 25/00 | |||
A61P 27/02 |
(11) | Number of the document | 1699924 |
(13) | Kind of document | T |
(96) | European patent application number | 04817632.5 |
Date of filing the European patent application | 2004-12-03 | |
(97) | Date of publication of the European application | 2006-09-13 |
(45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2004/004431 |
Date | 2004-12-03 |
(87) | Number | WO 2005/053600 |
Date | 2005-06-16 |
(30) | Number | Date | Country code |
529936 | 2003-12-03 | NZ |
(72) |
LAUX, Wilda, NZ
GREEN, Colin, R., NZ
|
(73) |
Ocunexus Therapeutics, Inc.,
101 West Broadway, Suite 900, San Diego, CA 92101,
US
|
(54) | INHIBITORY COMPOUNDS TARGETED TO CONNEXIN 43 AND METHODS OF USE THEREOF IN THE TREATMENT OF CORNEAL EYE TRAUMA |
INHIBITORY COMPOUNDS TARGETED TO CONNEXIN 43 AND METHODS OF USE THEREOF IN THE TREATMENT OF CORNEAL EYE TRAUMA |